Delivery Order SPE2DB25D3021-SPE2DB25FQYMP

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,515.98, is for the supply of CIPRO 10% SUSPENSION 100ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2024. Amerisourcebergen, through its Corporate Office Division, is the prime contractor for this award, which is...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,400.71 contract is for the supply of CIPRO 5% suspension, a prescription medication, with a performance period through August 17, 2022. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CIPRO 5% SUSPENSION 100ML. The contract has an ultimate completion date of May 14, 2025 and a ceiling value of $2,568.81. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $2,923.78 firm fixed price contract is for the supply of 4565393427 CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a completion date of August 9, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several significant Indefinite Delivery Contracts (IDCs) with the...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order, valued at $2,037.35, is for CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. The contract is for delivering a...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,783.38 firm-fixed-price delivery order is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 23, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major supplier of...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract valued at $1,321.18 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of CIPRO 500 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of August 21, 2024. This award is not associated with any set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various federal agencies, including the DLA...
The Defense Logistics Agency (DLA) awarded a $2,745.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CIPRO 500 MG tablets. The contract has an ultimate completion date of April 2, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The contract has a ceiling value of $3,406.75 and an ultimate completion date of August 28, 2024. The contract is a firm fixed-price delivery order, without a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,934.61 and a period of performance through April 4, 2024. It is for the provision of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. The company also...
  • SPE2DB25D3021
    Indefinite Delivery Contract
  • SPE2DB25D3021-SPE2DB25FQYMP
    Delivery Order

This is a $2,752.87 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of CIPRO 5% SUSPENSION 100ML. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and represents one of many federal contract awards the company has received to supply diverse medical products, including prescription medications, medical devices, and healthcare supplies to various government agencies. The contract allows DLA to order a wide range of pharmaceuticals across multiple therapeutic categories to support military and veteran healthcare programs.

Generated 8/24/25, 12:55 AM